Michel Marre

50.3k total citations · 4 hit papers
423 papers, 17.2k citations indexed

About

Michel Marre is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Michel Marre has authored 423 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Endocrinology, Diabetes and Metabolism, 103 papers in Cardiology and Cardiovascular Medicine and 90 papers in Surgery. Recurrent topics in Michel Marre's work include Diabetes Treatment and Management (99 papers), Diabetes Management and Research (62 papers) and Blood Pressure and Hypertension Studies (59 papers). Michel Marre is often cited by papers focused on Diabetes Treatment and Management (99 papers), Diabetes Management and Research (62 papers) and Blood Pressure and Hypertension Studies (59 papers). Michel Marre collaborates with scholars based in France, United Kingdom and United States. Michel Marre's co-authors include John Chalmers, Mark Woodward, Beverley Balkau, Sophia Zoungas, Anushka Patel, Ronan Roussel, Bruce Neal, Frédéric Fumeron, Simon Heller and Philippe Froguel and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Michel Marre

405 papers receiving 16.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Severe Hypoglycemia and Risks of Vascular Events and Death

2010 1.1k citations Sophia Zoungas, Anushka Patel et al. profile →
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

2009 692 citations Vlado Perkovic, Sophia Zoungas et al. profile →
Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU)

2009 687 citations Michel Marre et al. profile →
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

2019 283 citations Michel Marre et al. profile →

Peers

Countries citing papers authored by Michel Marre

Since Specialization

Citations

This map shows the geographic impact of Michel Marre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Marre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Marre more than expected).

Fields of papers citing papers by Michel Marre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Marre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Marre. The network helps show where Michel Marre may publish in the future.

Co-authorship network of co-authors of Michel Marre

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Marre. A scholar is included among the top collaborators of Michel Marre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Marre. Michel Marre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial 2024 ·PubMed ·Katie Harris, Jessica Gong, Stephen MacMahon, Ying Xu, (unknown), Stephen Harrap, Neil Poulter, Michel Marre, Pavel Hamet, G. Mancia, Craig S. Anderson, Mark Woodward, John Chalmers	0
2	Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review 2024 ·Cardiovascular Diabetology ·Kamel Mohammedi, Michel Marre, François Alhenc‐Gelas	3
3	Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study 2024 ·Diabetes Obesity and Metabolism ·(unknown), Mark Woodward, (unknown), Stephen Harrap, Pavel Hamet, Giuseppe Mancia, Michel Marre, Neil R Poulter, John Chalmers, Katie Harris	3
4	Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas 2023 ·Diabetologia ·(unknown), (unknown), Raphaël Boutry, (unknown), Emmanuel Vaillant, Aurélie Dechaume, (unknown), Beverley Balkau, G. Charpentier, Sylvia Franc, Michel Marre, Morgane Baron, Martine Vaxillaire, Mehdi Derhourhi, Mathilde Boissel, Philippe Froguel, Amélie Bonnefond	4
5	Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes 2022 ·Diabetes Care ·Louis Potier, Kamel Mohammedi, Pierre‐Jean Saulnier, Frédéric Fumeron, Jean‐Michel Halimi, Nicolas Venteclef, Michel Marre, Samy Hadjadj, Ronan Roussel, Gilberto Velho	2
6	Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus 2018 ·Hypertension ·Toshiaki Ohkuma, Min Jun, Anthony Rodgers, Mark E. Cooper, Paul Glasziou, Pavel Hamet, Stephen Harrap, Giuseppe Mancia, Michel Marre, Bruce Neal, Vlado Perkovic, Neil R Poulter, Bryan Williams, Sophia Zoungas, John Chalmers, Mark Woodward, (unknown)	37
7	Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population 2018 ·JCI Insight ·(unknown), (unknown), Esther Meijer, Lyanne M. Kieneker, Sofia Enhörning, (unknown), Kamel Mohammedi, Michel Marre, Frédéric Fumeron, Beverley Balkau, Nadine Bouby, Lise Bankir, Stephan J. L. Bakker, Ronan Roussel, Olle Melander, Ron T. Gansevoort, Gilberto Velho	38
8	The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation 2015 ·Obesity ·(unknown), Benjamin Hennart, Robert Caïazzo, Audrey Leloire, Loïc Yengo, Marie Verbanck, Abdelilah Arredouani, Michel Marre, Marie Pigeyre, Alban Bessede, Gilles J. Guillemin, Giulia Chinetti, Bart Staels, François Pattou, Beverley Balkau, Delphine Allorge, Philippe Froguel, Odile Poulain‐Godefroy	208
9	The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? 2013 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), M. Ng, John Chalmers, Mark Woodward, Giuseppe Mancia, Neil R Poulter, Michel Marre, Mark E. Cooper, Sophia Zoungas, (unknown)	5
10	Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes 2011 ·PLoS ONE ·Maija Wessman, Carol Forsblom, Mari Kaunisto, Jenny Söderlund, Jorma Ilonen, Riitta Sallinen, Tero Hiekkalinna, Maija Parkkonen, Alexander P. Maxwell, Lise Tarnow, Hans‐Henrik Parving, Samy Hadjadj, Michel Marre, Leena Peltonen, Per‐Henrik Groop, (unknown)	10
11	Adding Liraglutide to Oral Antidiabetic Drug Monotherapy: Efficacy and Weight Benefits 2009 ·Postgraduate Medicine ·Michael A. Nauck, Michel Marre	26
12	Cardiovascular (CV) Risk Evaluation in People with Type 2 Diabetes (T2D) on Insulin Therapy (CREDIT) Study-CV Disease and CV Risk at Baseline 2009 ·UCL Discovery (University College London) ·Nick Freemantle, Beverley Balkau, N Danchin, (unknown), Michel Marre, Philip Home, Lawrence Blonde	1
13	Cardiovascular Risk Evaluation in People with Type 2 Diabetes (T2D) on Insulin Therapy (CREDIT) Study: Patterns of Initial Prescription of Insulin and Associated Changes in Oral Glucose-Lowering Drug (OGLD) Therapy 2009 ·UCL Discovery (University College London) ·Michel Marre, N Danchin, Nick Freemantle, Beverley Balkau, (unknown), Lawrence Blonde, Philip Home	2
14	Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial 2008 ·Journal of Hypertension ·(unknown), John Chalmers, Vlado Perkovic, T. Ninomiya, Avinesh Pillai, Anushka Patel, Alan Cass, Stephen MacMahon, Bruce Neal, Mogensen Ce, Michel Marre, Stephen Harrap, N. Poulter, (unknown), Giuseppe Mancia	1
15	Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis 2000 ·Diabetes Care ·Michel Lièvre, François Gueyffier, Tord Ekbom, Robert Fagard, (unknown), Eleanor Schron, Michel Marre, J. P. Boissel	18
16	Lack of contribution of two endotelial nitric oxide synthase (eNOS) gene polymorphisms to diabetic nephropathy in type 1 diabetes 1999 ·Open Repository and Bibliography (University of Liège) ·Laurent Weekers, Samy Hadjadj, (unknown), Yves Gallois, Béatrice Bouhanick, Michel Marre	4
17	Contribution of Angiotensin I Converting Enzyme I/D polymorphism to the development and progression of diabetic nephropathy in type 1 diabetes: a 6-year follow-up observational study 1999 ·Open Repository and Bibliography (University of Liège) ·Samy Hadjadj, (unknown), Yves Gallois, Béatrice Bouhanick, Gilles Berrut, Laurent Weekers, Michel Marre	1
18	Necrobiosis lipoidica: treatment by hyperbaric oxygen and local corticosteroids. 1998 ·PubMed ·Béatrice Bouhanick, J L Verret, J.P. Gouëllo, Gilles Berrut, Michel Marre	15
19	Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. 1997 ·Journal of Clinical Investigation ·Michel Marre, Xavier Jeunemaı̂tre, Yves Gallois, M. Rodier, Gilles Châtellier, Caroline Sert, L. Dusselier, (unknown), Lucy Chaillous, S. Halimi, Ulrich Müller, (unknown), B. Bauduceau, F. Bled, P Passa, F Alhenc‐Gelas	251
20	[Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics]. 1987 ·PubMed ·Hélène Leblanc, Michel Marre, (unknown), P Passa	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact